Persons with dispensed medicines; origin
| Sex | Age | Origin | Medicine group (ATC) | Periods | Persons with medicines, relative (%) | Defined daily doses (DDD), relative (number per 1 000 persons) |
|---|---|---|---|---|---|---|
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A Alimentary tract and metabolism | 2022* | 16.12 | 61,047 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A02B Drugs for peptic ulcer and gord | 2022* | 6.32 | 22,172 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A03B Belladonna and derivatives, plain | 2022* | 0.02 | 1 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A03E Antispasmodics and anticholinergics | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A04 Antiemetics and antinauseants | 2022* | 0.68 | 60 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A04A Antiemetics and antinauseants | 2022* | 0.68 | 60 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A05 Bile and liver therapy | 2022* | 0.08 | 201 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A05C Bile therapy drugs and lipotropics | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A10A Insulins and analogues | 2022* | 0.86 | 5,029 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A11C Vit A and D, incl.combin.of the two | 2022* | 2.81 | 11,446 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 0.01 | 4 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | A16A Oth.aliment.tract and metabol.prod. | 2022* | 0.02 | 47 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | B Blood and blood forming organs | 2022* | 6.24 | 24,263 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | B02B Vitamin k and other hemostatics | 2022* | 0.03 | 20 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | B03B Vitamin B12 and folic acid | 2022* | 1.24 | 13,061 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | B05Z Hemodialytics and hemofiltrates | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | C01B Antiarrhythmics, class I and III | 2022* | 0.13 | 269 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | C07B Beta blocking agents and thiazides | 2022* | 0.03 | 117 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | D02 Emollients and protectives | 2022* | 5.09 | 18,095 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | D02A Emollients and protectives | 2022* | 5.09 | 18,095 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | D08 Antiseptics and disinfectants | 2022* | 0.00 | 39 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | D08A Antiseptics and disinfectants | 2022* | 0.00 | 39 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | G Genito urinary system and sex hormones | 2022* | 5.87 | 15,926 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | G03B Androgens | 2022* | 0.13 | 269 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | G03E Androgens / female sex hormon.comb. | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | G03H Antiandrogens | 2022* | 0.01 | 8 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | H05A Parathyroid hormones and analogues | 2022* | 0.00 | 11 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | J01E Sulfonamides and trimethoprim | 2022* | 0.57 | 100 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | J06 Immune sera and immunoglobulins | 2022* | 0.05 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | J07C Bacterial and viral vaccines,combi. | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | L Antineoplastic and immunomodul. agents | 2022* | 1.30 | 3,040 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | L01F Monoclonal antbodies and a.d.c. | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | L02A Hormones and related agents | 2022* | 0.10 | 255 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | M02A Joint and muscular pain top. prod. | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | M05B Bone structure and mineralization . | 2022* | 0.37 | 1,142 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | N02B Other analgesics and antipyretics | 2022* | 0.02 | 2 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | N05C Hypnotics and sedatives | 2022* | 0.89 | 1,523 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | P01C Leishmaniasis and trypanosomiasis | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | P03B Insecticides and repellents | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | R05 Cough and cold preparations | 2022* | 2.81 | 205 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | R05F Cough suppressants and expectorants | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | S01F Mydriatics and cycloplegics | 2022* | 0.17 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin: born in the Netherlands | S01G Decongestants and antiallergics | 2022* | 1.43 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A Alimentary tract and metabolism | 2022* | 15.62 | 59,129 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A02B Drugs for peptic ulcer and gord | 2022* | 6.34 | 22,391 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A03B Belladonna and derivatives, plain | 2022* | 0.02 | 1 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A03E Antispasmodics and anticholinergics | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A04 Antiemetics and antinauseants | 2022* | 0.65 | 60 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A04A Antiemetics and antinauseants | 2022* | 0.65 | 60 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A05 Bile and liver therapy | 2022* | 0.07 | 201 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A05C Bile therapy drugs and lipotropics | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A10A Insulins and analogues | 2022* | 0.85 | 4,971 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A11C Vit A and D, incl.combin.of the two | 2022* | 2.30 | 9,515 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A11D Vitamin B1,and with vit. B6 and B12 | 2022* | 0.01 | 4 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | A16A Oth.aliment.tract and metabol.prod. | 2022* | 0.02 | 44 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | B Blood and blood forming organs | 2022* | 6.08 | 24,465 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | B02B Vitamin k and other hemostatics | 2022* | 0.03 | 20 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | B03B Vitamin B12 and folic acid | 2022* | 1.24 | 13,249 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | B05A Blood and related products | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | B05Z Hemodialytics and hemofiltrates | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | C01B Antiarrhythmics, class I and III | 2022* | 0.14 | 273 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | C07B Beta blocking agents and thiazides | 2022* | 0.03 | 117 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | D02 Emollients and protectives | 2022* | 4.75 | 15,882 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | D02A Emollients and protectives | 2022* | 4.75 | 15,882 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | D08 Antiseptics and disinfectants | 2022* | 0.00 | 38 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | D08A Antiseptics and disinfectants | 2022* | 0.00 | 38 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | G Genito urinary system and sex hormones | 2022* | 6.08 | 17,317 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | G03B Androgens | 2022* | 0.13 | 271 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | G03E Androgens / female sex hormon.comb. | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | G03H Antiandrogens | 2022* | 0.01 | 9 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | H05A Parathyroid hormones and analogues | 2022* | 0.00 | 12 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | J01E Sulfonamides and trimethoprim | 2022* | 0.57 | 101 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | J06 Immune sera and immunoglobulins | 2022* | 0.05 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | J07C Bacterial and viral vaccines,combi. | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | L Antineoplastic and immunomodul. agents | 2022* | 1.30 | 3,027 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | L01F Monoclonal antbodies and a.d.c. | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | L02A Hormones and related agents | 2022* | 0.10 | 257 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | M02A Joint and muscular pain top. prod. | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | M05B Bone structure and mineralization . | 2022* | 0.37 | 1,150 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | N02B Other analgesics and antipyretics | 2022* | 0.02 | 2 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | N05C Hypnotics and sedatives | 2022* | 0.86 | 1,481 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | P01C Leishmaniasis and trypanosomiasis | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | P03B Insecticides and repellents | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | R05 Cough and cold preparations | 2022* | 2.79 | 205 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | R05F Cough suppressants and expectorants | 2022* | 0.00 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | S01F Mydriatics and cycloplegics | 2022* | 0.15 | 0 |
| Total male and female | 0 to 64 years, standardised | Origin country: The Netherlands | S01G Decongestants and antiallergics | 2022* | 1.32 | 0 |
| Source: CBS. | ||||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, origin, age and sex.
Data available from 2020.
Status of the figures:
Figures for 2022 are provisional.
Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.
When will new figures be published?
New figures will be published in the last quarter of 2024.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.
- Defined daily doses (DDD), relative
- Defined Daily Dose (DDD) is de door de WHO vastgestelde gemiddelde dagelijkse dosis van een geneesmiddel, wanneer het geneesmiddel wordt ingezet voor de hoofdindicatie, bij een onderhoudsbehandeling voor volwassenen. Deze definitie maakt het mogelijk om het gebruik van verschillende toedieningsvormen en verschillende middelen met elkaar te vergelijken.
WHO: World Health Organisation, Wereldgezondheidsorganisatie